Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
  • Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
  • Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
  • START Mountain Region /ID# 267592 West Valley City, Utah, United States
View all 14 locations
View Trial Details
Active, not recruiting

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

NCT01840566

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +31 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 210548 Tucson, Arizona, United States
  • UCLA Santa Monica Hematology Oncology /ID# 210551 Los Angeles, California, United States
  • Ingalls Memorial Hosp /ID# 210553 Harvey, Illinois, United States
  • Dana-Farber Cancer Institute /ID# 215360 Boston, Massachusetts, United States
View all 56 locations
View Trial Details
Active, not recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT05618028

Conditions
B Cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +21 more
Locations
  • University of California Los Angeles Medical Center /ID# 246357 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 259081 New Haven, Connecticut, United States
  • Mount Sinai Medical Center-Miami Beach /ID# 248251 Miami Beach, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113 Fort Wayne, Indiana, United States
View all 39 locations
View Trial Details
Active, not recruiting

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

NCT03075696

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Mount Sinai Medical Center New York, United States
  • MSKCC New York, United States
View all 34 locations
View Trial Details

Related conditions